Cite
MLA Citation
Makoto Ueno et al.. “Nal‐IRI+5‐FU/LV versus 5‐FU/LV in post‐gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients.” Cancer medicine, vol. 9, 2020, pp. 9396–9408. http://access.bl.uk/ark:/81055/vdc_100118555518.0x000002